Form 4: DocGo CEO Lee Bienstock Reports Stock Transactions

DocGo Inc. CEO Lee Bienstock reported a transaction involving the withholding of restricted stock units to cover tax liabilities, alongside details of his beneficial ownership of common stock and unvested RSUs.

Summary

• Lee Bienstock, CEO of DocGo Inc., reported a transaction on May 12, 2026, where restricted stock units (RSUs) were withheld to satisfy tax obligations.
• The transaction involved 15,644 RSUs, with a price of $0.59, which were disposed of.
• Following this transaction, Bienstock beneficially owns 2,801,826 shares of common stock directly.
• Additionally, Bienstock holds 402,745 RSUs that will vest in three equal annual installments on December 12, 2026, 2027, and 2028.
• He also holds 30,487 RSUs vesting on May 12, 2027.
• Further RSUs include 570,402 vesting in two equal annual installments on December 12, 2026, and December 12, 2027.
• Lastly, 1,113,495 RSUs are set to vest in four equal annual installments starting from December 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction for tax settlement and details existing equity awards rather than new strategic developments or financial performance indicators.

Positives

• Lee Bienstock, as CEO, continues to hold a significant beneficial ownership of DocGo Inc. common stock (2,801,826 shares).
• A substantial number of RSUs are scheduled to vest over the next few years, indicating continued incentive alignment with the company's performance.
• The withholding of RSUs for tax purposes is a standard procedure and does not necessarily indicate a negative view of the stock.

Negatives

• The disposal of 15,644 RSUs to cover tax liabilities represents a reduction in immediate beneficial ownership, although it's a common practice.
• The vesting schedules for the RSUs indicate a phased release of equity, meaning a significant portion of his potential holdings are not yet fully realized.

Risks

• The vesting of a large number of RSUs in the coming years could lead to increased selling pressure on the stock if the recipients decide to sell upon vesting.
• The value of the unvested RSUs is subject to the future performance and stock price of DocGo Inc.

Future Outlook

The filing details the vesting schedules for various tranches of Restricted Stock Units (RSUs) granted to Lee Bienstock, with vesting dates extending through December 12, 2028. These RSUs represent future potential equity ownership contingent upon continued service and the terms of the Issuer's 2021 Stock Incentive Plan.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders and reflect standard equity compensation practices. The details provided by DocGo Inc.'s CEO regarding RSU vesting and tax settlements are typical for executives in the technology and healthcare services sectors, where equity-based compensation is prevalent.

Stakeholder Impact

• Shareholders: The filing provides transparency on executive equity holdings and potential future share issuances upon RSU vesting, which could impact share count and market dynamics.
• Employees: The details of the stock incentive plan and RSU vesting reinforce the company's use of equity compensation to retain and motivate key personnel.
• Management: The transaction reflects standard executive compensation practices and tax management.

Next Steps

• Vesting of RSUs according to the specified schedules on December 12, 2026, December 12, 2027, December 12, 2028, and May 12, 2027.
• Potential sale of vested shares by the reporting person, subject to market conditions and personal financial planning.

Key Dates

Keywords

DocGo Inc., DCGO, Form 4, SEC Filing, Insider Trading, Stock Transaction, Restricted Stock Units, RSUs, Beneficial Ownership, Lee Bienstock, CEO, Tax Liability